BGNE (BeiGene Ltd.) Cumulative Company Assets

Official company branding of BeiGene Ltd. (BGNE)

The financial price visualization of BeiGene, Ltd. (BGNE) total assets, valued at 7741.22, demonstrates the resources of a global leader in the development of immunotherapy and targeted drugs. BeiGene, Ltd. (BGNE) relies on an advanced rapid compound analysis system to combat tumors. However, the business faces the risk of delisting from US exchanges and severe pressure from PRC regulators due to the trade confrontation.

BeiGene Ltd. (BGNE) Aggregate Company Assets: for the period 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for BeOne Medicines (BGNE)

- stock value and consensus price forecast:
Market Price beigene.com|BGNE - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation BeiGene Ltd|BGNE - Enterprise Value
- company book value details:
Book Value per Share BeiGene|BGNE - Company Book Value|Capitalization to Book Value Ratio beigene.com|BGNE - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio BeiGene, Ltd.|BGNE - Long-Term Debt to Capital|Current Liabilities to Capital BeiGene Ltd|BGNE - Company Debts|Debt to Net Assets Ratio BeiGene Ltd|BGNE - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings BeiGene|Quick Liquidity Indicator beigene.com
- earnings and market multiples details:
BGNE - Net Income
Basic company analysis:beigene.com (BGNE)
Core merchandise of BeiGene

An analysis of the total balance sheet assets of BeiGene, Ltd. (BGNE) reflects the resource base of a biotechnology leader in the development of targeted oncology drugs, where the total value of assets and liabilities, reverse-calculated via ROA, transforms balance sheet statics into a dynamic trend, allowing investors to assess the scale of the business and its financial stability during the deployment of a global innovative healthcare infrastructure.

Key competitors

Company Assets beigene.com (ONC)|HALO (Halozyme) - Company Total Assets|Cumulative Company Assets Revolution Medicines Inc (RVMD)|Company Total Assets AAPG|Company Total Assets CG Oncology Therapeutics (CGON)|Aggregate Company Assets UroGen Pharma Ltd. URGN|BCAX: Total Business Assets|Personalis - Company Total Assets|Erasca Inc (ERAS) - Cumulative Company Assets|DCTH: Company Total Assets|Company Assets Y-mAbs Corp (YMAB)|Aggregate Company Assets Aura Biosciences, Inc.|CADL: Aggregate Asset Value|Cumulative Company Assets ARAY (Accuray)|SLS (sellaslifesciences.com) - Aggregate Asset Value|Company Total Assets ACTU (Actuate Therapeutics, Inc)|CTOR - Cumulative Company Assets|HURA: Cumulative Company Assets|TARA - Company Total Assets|Fate Therapeutics (FATE) - Aggregate Company Assets|Aadi Bioscience - Aggregate Asset Value|TCRX (TScan Therapeutics Inc) - Company Total Assets|Company Assets Champions Oncology Corp CSBR|Company Total Assets XBIT|Aggregate Company Assets CVM (cel-sci.com)|Company Total Assets OSTX (OS Therapies)|radiopharmtheranostics.com (RADX) - Company Assets|Artiva - Company Total Assets|Company Total Asset Base Adlai Nortye Ltd. ANL|VERU: Company Total Assets|Company Balance Sheet Assets tempesttx.com TPST|XLO (Xilio Therapeutics Inc) - Company Total Assets|Company Assets Enochian BioSciences RENB|Aggregate Company Assets Mural Oncology plc (MURA)|kairospharma.com - Total Business Assets|Company Total Assets OKUR (OnKure Therapeutics)|CytoMed Therapeutics Ltd (GDTC) - Company Assets|CRIS: Cumulative Company Assets|Aggregate Asset Value APLM (Apollomics, Inc.)|Tharimmune Corp (THAR) - Aggregate Company Assets|ADVB (Advanced Biomed) - Aggregate Company Assets|Cumulative Company Assets GNPX|CLDI (Calidi Bio) - Aggregate Business Assets|Company Total Assets SBFM|xeneticbio.com - Total Business Assets|Salarius - Cumulative Company Assets|Company Total Asset Base Kitov Pharma (PPBT)|AON - Company Total Assets|CKPT: Aggregate Company Assets|ELEV: Company Total Assets|Company Balance Sheet Assets iCAD ICAD|Aggregate Company Assets Ikena Oncology Inc.|Total Business Assets NTBL (Notable Labs Corp)|Company Total Assets VIRX|MOR - Company Assets|Company Total Assets NAYA (NAYA Biosciences Inc.)|AAPGV - Cumulative Company Assets